PALUMBO, Antonio

PALUMBO, Antonio  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 89 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
12p, 1p, 1q, 5q, 11q ABNORMALITIES AND IMMUNOPHENOTYPE IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA. 2010 Ruggeri M; Caltagirone S; Gilestro M; Aschero S; Astolfi M; Oddolo D; Saraci E; Bruno B; Palumbo A; Bringhen S; Cavallo F; Omedè P; Boccadoro M
A Multicenter, Open Label Study of Oral Lenalidomide and Prednisone (RP) Followed by Oral Lenalidomide Melphalan and Prednisone (MPR) and Oral Lenalidomide Maintenance In Newly Diagnosed Elderly Multiple Myeloma Patients 2010 Palumbo A; Falco P; Benevolo G; Rossi D; Carella AM; Guglielmelli T; Rocci A; De Paoli L; Grasso M; Mosca Siez ML; Piro E; Caltagirone S; Gay F; Cavallo F; Gaidano G; Boccadoro M
A Phase 3 Study Evaluating the Efficacy and Safety of Lenalidomide (Len) Combined with Melphalan and Prednisone Followed by Continuous Lenalidomide Maintenance (MPR-R) in Patients (Pts) ≥ 65 Years (Yrs) with Newly Diagnosed Multiple Myeloma (NDMM): Updated Results for Pts Aged 65-75 Yrs Enrolled in MM-015 2011 Palumbo A; Adam Z; Kropff M; Foà R; Catalano J; Gisslinger H; Wiktor-Jedrzejczak W; Delforge M; Weisel K; Cascavilla N; Van Droogenbroeck J; Iosava G; Cavo M; Blade J; Beksac M; Spicka I; Plesner T; Yu Z; Herbein L; Mei J; Jacques CJ; Dimopoulos MA
A PHASE 3 STUDY TO DETERMINE THE EFFICACY AND SAFETY OFLENALIDOMIDE COMBINED WITH MELPHALAN AND PREDNISONE INPATIENTS = 65 YEARS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA(NDMM) 2010 A Palumbo; M Dimopoulos; M Delforge; R Hajek; M Kropff; MT Petrucci; Z Yu; L Herbein; J Mei; C Jacques; J Catalano
A PHASE III STUDY OF ENOXAPARIN VS ASPIRIN AS THROMBOPROPHYLAXIS FOR PATIENTS WITH NEWLY DIAGNOSED OF MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE-BASED REGIMENS. 2011 F. CAVALLO; T. CARAVITA; F. DI RAIMONDO; G. CICCONE; B. LUPO; M. MARCATTI; A. BARALDI; N. PESCOSTA; A.P. FALCONE ;R. RIA; L. BALDINI; L. MASINI; T. GUGLIELMELLI; G. GAIDANO; G. BENEVOLO; C. CANGIALOSI ; M. GALLI ; L. CATALANO; A. LAROCCA; A. NAGLER; M. BOCCADORO; A. PALUMBO
A Phase III Study to Determine the Efficacy and Safety of Lenalidomide in Combination with Melphalan and Prednisone (MPR) in Elderly Patients with Newly Diagnosed Multiple Myeloma 2008 Palumbo A; Dimopoulos MA; Delforge M; Kropff M; Foa R; Yu Z; Herbein L; Mei J; Jacques C; Catalano J
A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo. 2007 B. Bruno; M. Rotta; F. Patriarca; D. Mattei; B. Allione; F. Carnevale-Schianca; A. Rambaldi; M. Casini; V. Montefusco; M. Parma; P. Bavaro; F. Onida; A. Busca; L. Castagna; M.P. Iori; D. Maloney; B. Sandmaier; F. Benedetti; N. Mordini; L. Giaccone; R. Sorasio; F. Fiore; A. Filippi; A. Palumbo; M. Aglietta; A. Levis; R. Foà; P. Di Bartolomeo; E. Pogliani; G. Lambertenghi-Deliliers; M. Falda; M. Petrini; P. Corradini; R. Fanin; U. Ricardi; R. Storb; I. Baldi; and Mario Boccadoro
A PROSPECTIVE PHASE II STUDY ON TANDEM AUTOGRAFTING-ONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL RESULTS OF A MULTICENTER GITMO (GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO) PROTOCOL 2007 Sorasio R; Patriarca F; Giaccone L; Mattei D; Allione B; Carnevale-Schianca F; Rambaldi A; Casini M; Montefusco V; Parma M; Bavaro P; Onida F; Busca A; Castagna L; Iori AP; Rotta M; Fiore F; Benedetti E; Mordini N; Massaia M; Palumbo A; Aglietta M; Lewis A; Foà R; Di Bartolomeo P; Pogliani E; Lambertenghi-Deliliers G; Falda M; Petrini M; Corradini P; Fanin R; Ricardi U; Ciccone G; Baldi I; Bruno B; Boccadoro M
A PROSPECTIVE RANDOMIZED TRIAL OF BORTEZOMIB-MELPHALANPREDNISONE-THALIDOMIDE FOLLOWED BY CONTINUOUS BORTEZOMIB-THALIDOMIDE FOR INITIAL THERAPY OF MULTIPLE MYELOMA:EFFECT OF AGE AND CO-MORBIDITIES 2010 A Palumbo; S Bringhen; D Rossi; M Cavalli; R Ria; M Offidani; C Nozzoli; L Baldini; L De Rosa; G De Sabbata; AM Liberati; C Crippa; F Ciambelli; V Callea; M Spriano; F Ferrara; F Elice; M Galli; J Peccatori; L Catalano; M Rizzo; R Marasca; F Pisani; M Cavo; M Petrucci; P Musto; P Omedè; A Larocca; G Gaidano; M Boccadoro
A Prospective Randomized Trial of Oral Melphalan, Prednisone, Thalidomide (MPT) vs Oral Melphalan, Prednisone (MP): An Interim Analysis. 2004 Palumbo A; Bertola A; Musto P; Caravita T; Callea V; Cangialosi C; Liberati AM; Niscola P; Catalano L; Grasso M; Lauta VM; Petti MC; Morandi S; Galli S; Bringhen S; Cavallo F; Falco P; Boccadoro M
A Prospective, Randomized, Phase III Study of Enoxaparin Versus Aspirin Versus Low-Fixed-Dose of Warfarin in Newly Diagnosed Myeloma Patients Treated with Thalidomide-Containing Regimens. 2007 Palumbo A; Cavo M; Bringhen S; Perrone G; Magarotto V; Patriarca F; Petrucci MT; Galli M; Di Raimondo F; Rossi D; Marasca R; Offidani M; Goldaniga M; Corradini P; Crippa C; Catalano L; Callea V; Gozzini A; Tosi P; Boccadoro M
A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m2 (Mel200) Versus Melphalan 100 mg/m2 (Mel100) in Newly Diagnosed Myeloma Patients. 2007 Palumbo A; Bringhen S; Petrucci MT; Falcone A; Liberati AM; Lauta VM; Grasso M; Montanaro M; Pisani F; Caravita T; Cangialosi C; Pregno P; Nozza A; Calabrese E; Gay F; Cavallo F; Omedè P; Musto P; Foà R; Boccadoro M
A Simple Score, Based On Geriatric Assessment, Improves Prediction of Survival, and Risk Of Serious Adverse Events In Elderly Newly Diagnosed Multiple Myeloma Patients 2013 Larocca, A; Bringhen, S; Evangelista, A; Offidani, M; Ballanti, S; Zaccaria, A; Pescosta, N; Montefusco, V; De Rosa, L; Carella, Am; Baldini, L; Aglietta, M; Vincelli, Id; Marasca, R; Pezzati, S; Tosi, P; Cocito, F; Grasso, M; Fioritoni, G; Pavone, V; Musto, P; Grammatico, S; Omede, P; Gay, F; Ciccone, G; Boccadoro, M; Palumbo, A
ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS 2010 F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo
An Update of a Comparison of Nonmyeloablative Allografting with Autografting for Newly Diagnosed Myeloma. 2007 B. Bruno; R. Sorasio; F. Patriarca; N. Mordini; B. Allione; F. Carnevale-Schianca; L. Giaccone; M. Rotta; P. Omedè; I. Baldi; S. Bringhen; M. Massaia; M. Aglietta; A. Levis; D. Mattei; R. Fanin; A. Palumbo; R. Storb; G. Ciccone; and Mario Boccadoro
AUTOGRAFTING FOLLOWED BY LOW DOSE TBI BASED NON MYELOABLATIVE ALLOGRAFTING IN MULTIPLE MYELOMA: THE GITMO EXPERIENCE 2003 Bruno B; Patriarca F; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soglio D; Bavaro P; Rotta M; Aitoro G; Corradini P; Todisco E; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Messina M; Palumbo A; Sandmaier B; Storb R; Boccadoro M
AUTOGRAFTING FOLLOWED BY LOW DOSE TBI BASED NON MYELOABLATIVE ALLOGRAFTING IN NEWLY DIAGNOSED MULTIPLE MYELOMA: THE ITALIAN EXPERIENCE 2004 Bruno B; Patriarca F; Rotta M; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soligo D; Bavaro P; Giaccone L; Aitoro G; Corradini P; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Massaia M; Palumbo A; Sandmaier B; Storb R; Boccadoro M
Autografting followed by low dose TBI based non myeloablative allografting in newly diagnosed multiple myeloma: The Italian experience. 2003 Bruno B; Patriarca F; Rotta M; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soligo D; Bavaro P; Giaccone L; Aitoro G; Corradini P; Busca A; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Pogliani E; Falda M; Bianchi A; Massaia M; Palumbo A; Sandmaier B; Storb R; Boccadoro M
AUTOGRAFTING FOLLOWED BY NON MYELOABLATIVE TBI-BASED ALLOGRATING FOR TREATMENT OF MULTIPLE MYELOMA: A MULTI-CENTER TRIAL 2002 Bruno B; Patriarca F; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale F; Allione B; Soligo D; Bavaro P; Aitoro G; Corradini P; Fanin R; Gallamini A; Coser P; Levis A; Aglietta M; Massaia M; Palumbo A; Sandmaier B; Storb R; Boccadoro M
Bortezomib (VEL) Based Regimens in Multiple Myeloma (MM) Patients with Renal Impairment (RI): A Preliminary Retrospective Italian Multicenter Study 2008 Massimo Gentile; Stefania Ciolli; Maria Teresa Petrucci; Sara Galimberti; Giuseppe Mele; Antonio Francesco Casulli; Donato Mannina; Eugenio Piro; Graziella Pinotti; Salvatore Palmieri; Lucio Catalano; Vincenzo Callea; Massimo Offidani; Pellegrino Musto; Sara Bringhen; Luca Baldini; Patrizia Tosi; Francesco Di Raimondo; Mario Boccadoro; Antonio Palumbo; Michele Cavo; and Fortunato Morabito